EGFR and head and neck squamous cell carcinoma: The potential of EGFR-directed therapy to treat patients with HNSCC has been validated in recent trials in which patients receiving cetuximab and radiation demonstrated improved survival and locoregional control, as opposed to treatment with radiation alone [16].